Table 2.

AEs considered related to BI 836826 occurring in ≥ 2 patients

	Any-grade n (%)	Grade 3/4 n (%)
Any treatment-related AEs	16 (76.2)	12 (57.1)
Neutropenia	11 (52.4)	10 (47.6)
Anemia	10 (47.6)	6 (28.6)
Thrombocytopenia	10 (47.6)	9 (42.9)
Infusion-related reaction	8 (38.1)	2 (9.5)
Decreased white blood cell count	7 (33.3)	7 (33.3)
Increased AST	2 (9.5)	0
Increased GGT	2 (9.5)	1 (4.8)
Asthenia	2 (9.5)	0
Pyrexia	2 (9.5)	0
Decreased platelet count	1 (4.8)	1 (4.8)
Pancytopenia	1 (4.8)	1 (4.8)
Increased ALT	1 (4.8)	0
Chills	1 (4.8)	0
Cough	1 (4.8)	0
Dizziness	1 (4.8)	0
Hyperuricemia	1 (4.8)	0
Nausea	1 (4.8)	0
Vomiting	1 (4.8)	0

ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transferase